Candida

  1. Anon.  Drugs for vulvovaginal candidiasis.  Med Lett 2001;43:3-4.
  2. Achkar JM, Fries BC.  Candida infections of the genitourinary tract.  Clin Microbiol Rev 2010;23:253.
  3. Bow EJ, Evans G, Fuller J, et al.  Canadian clinical practice guidelines for invasive candidiasis in adults.  Can J Infect Dis Med Microbiol 2010;21:122-50.
  4. Breazzano MP, Day HR Jr, Bloch KC, et al. Utility of ophthalmologic screening for patients with Candida bloodstream infections: a systematic review. JAMA Ophthalmol. doi:10.1001/jamaophthalmol.2019.0733 
  5. Deresinski S. Candidemia: Does every patient need a complete retinal examination by an ophthalmologist? Editorial-In the Literature Clin Infect Dis 2019;69:iii. https://academic.oup.com/cid/article/69/8/iii/5574695
  6. Edwards JEJ, Bodey GP, Bowden RA, et al.  International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 1997;25:43-59.
  7. Fisher JF, Sobel JD, Kauffman CA, et al.  Candida urinary tract infections - treatment.  Clin Infect Dis 2011;52:457-66.
  8. Kim BJ. Utility of ophthalmic consultations for patients with candidemia. JAMA Ophthalmol 2019;137:698-710. https://pubmed.ncbi.nlm.nih.gov/30998822/
  9. Kulberg BJ, Verweij PE, Akova M, et al.  European expert opinion on the management of invasive candidiasis in adults.  Clin Microbiol Infect 2011;17:1-12.
  10. Laupland KB, Gregson DB, Church DL, et al.  Invasive Candida species infections:  a 5 year population-based assessment.  J Antimicrob Chemother 2005;56:532-7.
  11. Lewis RE, Klepser ME.  The changing face of nosocomial candidemia:  epidemiology, resistance, and drug therapy.  Am J Health-Syst Pharm 1999;56:525-36.
  12.  
  13. Pappas PG, Kauffman CA, Andes D, et al.  Clinical practice guidelines for the management of candidiasis:  2009 update by the Infectious Diseases Society of America.  Clin Infect Dis 2009;48:503-35.
  14. Pappas PG, Kauffman CA, Andes DR, et al.  Clinical practice guidelines for the management of candidiasis:  2016 update by the Infectious Diseases Society of America.  Clin Infect Dis 2016;62:1-50.
  15. Pappas PG, Rex JH, Sobel JD, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis 2004;38:161-89.
  16. Pappas PG, Rotstein CMF, Betts RF, et al.  Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.  Clin Infect Dis 2007;45:883-93.
  17. Rex JH, Bennett JE, Sugar AM, et al.  A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia.  N Engl J Med 1994;331:1325-30.
  18. Rex JH, Pappas PG, Karchmer AW, et al.  A randomized and blinded trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis 2003;36:1221-8.
  19. Yamamura DLR, Rotstein C, Nicolle LE, et al.  Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994.  CMAJ 1999;160:493-9.